Zhengye Biotechnology Holding Limited (ZYBT)
Nasdaq: ZYBT · Pharmaceutical Preparations · Jilin · filing with the SEC since 2023
Income statement, as filed
In thousands of Chinese yuan (CNY), as filed; per-share figures in Chinese yuan; share counts.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Apr 28, 2026 | Jul 3, 2025 | · | · |
| Revenue | 116,362 | 186,356 | 211,651 | 260,269 |
| Cost of revenue | 92,493 | 95,061 | 94,143 | 112,390 |
| Gross profit | 23,869 | 91,295 | 117,508 | 147,879 |
| Research and development | 18,013 | 12,794 | 11,901 | 13,424 |
| Sales and marketing | 43,918 | 41,269 | 40,743 | 34,565 |
| General and administrative | 31,006 | 22,575 | 23,592 | 24,321 |
| Total operating expenses | 94,375 | 74,856 | 72,522 | 82,045 |
| Operating income | -70,506 | 16,439 | 44,986 | 65,834 |
| Interest expense | 3,400 | 4,043 | 4,423 | 2,839 |
| Interest and investment income | 96 | 231 | 312 | 114 |
| Other income (expense), net | -130 | 146 | 234 | · |
| Total non-operating income (expense) | -1,367 | -2,045 | -1,224 | -1,920 |
| Income before income taxes | -71,873 | 14,394 | 43,762 | 63,914 |
| Income tax expense | 11,095 | 924 | 6,253 | 8,172 |
| Net income including non-controlling interests | -82,968 | 13,470 | 37,509 | 55,742 |
| Net income to non-controlling interests | -13,184 | 2,159 | 6,052 | 9,007 |
| Net income | -69,784 | 11,311 | 31,457 | 46,735 |
| Earnings per share, basic | · | 0.25 | 0.69 | 1.02 |
| Earnings per share, diluted | · | 0.25 | 0.69 | 1.02 |
| Weighted average shares, basic | 47,349,869 | 45,666,376 | 45,666,376 | 45,666,376 |
| Weighted average shares, diluted | 47,349,869 | 45,666,376 | 45,666,376 | 45,666,376 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding